Speaker

Howard Scher, Memorial Sloan-Kettering Cancer Center, USA
Howard Scher

Howard I. Scher, MD is Chief of the Genitourinary Oncology Service at Memorial Sloan Kettering Cancer Center, Professor of Medicine at the Weill Cornell Medical College, and the D. Wayne Calloway Chair in Urologic Oncology. Dr. Scher has helped elucidate key molecular and genetic features of prostate cancer and has translated these insights into the clinical evaluation of novel targeted agents including abiraterone and enzalutamide. His research is focused on the validation of circulating tumor cell and other blood based biomarker assays to biologically profile individual patient tumors to better select and monitor the effects of therapy. Dr. Scher led the international Prostate Cancer Clinical Trials Working Group effort standardize the design and analysis of phase II trials, and serves as the principal investigator of an NIH-supported Specialized Program of Research Excellence in Prostate Cancer, Prostate Cancer Clinical Trials Consortium and the Department of Defense Transformative Impact Award: Toward the Practice of Precision Medicine – A Biomarker Validation Coordinating Center.

« Go Back

Supporting Publications
Cancer Cell
Immunity
Trends in Pharmacological Sciences
Trends in Molecular Medicine
Cell
Cell Reports
Cancer Therapeutics
In partnership with
  • CAMS
  • CSCO
Platinum Sponsor
 
Sanofi
Gold Sponsor
 
nanoString
Silver Sponsors
  • Haihe
  • Huawei
  • Janssen
  • Perkinelmer
  • Seahorse Bioscience
  • SIMM
  • Sino Biological
  • Tekon
  • ThermoFisher
  • Tissue Gnostics
Sponsor
  • CAMS
  • CSCO